scholarly journals The Dangers of Immediately Performing a Sensitive and Specific Investigation versus the Dangers of Delaying It: A Cautionary Case of Hodgkin’s Lymphoma

Author(s):  
Takahiro Ito ◽  
Hiroshi Sawachika ◽  
Yukinori Harada ◽  
Taro Shimizu

A 60-year-old man was admitted with a 1-month history of fever and weight loss. Multiple lymphadenopathies and haemophagocytic lymphohistiocytosis were noted from the beginning, suggesting lymphoma. However, lymph node biopsy was deferred because lymph node biopsy was regarded as being invasive and requires general anaesthesia, and because other possible differential diagnoses including gastrointestinal malignancies and TAFRO syndrome were being considered. Instead, investigations including gastrointestinal endoscopy and bone marrow biopsy were prioritized. The patient was eventually diagnosed with Hodgkin’s lymphoma based on lymph node biopsy but died during chemotherapy. Physicians should prioritize the tests that are most directly related to the diagnostic outcome, even if they are invasive.

1986 ◽  
Vol 75 (4) ◽  
pp. 199-202
Author(s):  
Ahnond Bunyaratvej ◽  
Pattraporn Boonkanta ◽  
Prawat Nítiyanant ◽  
Suntaree Apibal ◽  
Natth Bhamarapravati

Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 5318-5318
Author(s):  
Prabhsimranjot Singh ◽  
Sudhamshi Toom ◽  
Makardhwaj S Shrivastava ◽  
Jason Shaw ◽  
David A Silver ◽  
...  

Abstract Introduction: Second malignancies, including lymphoma, occur at a higher incidence in men previously treated for germ cell tumors than in the general population (1). Synchronous presentation of seminoma and lymphoma is rare but has important ramifications for the treatment of both malignancies. Without clinical vigilance this situation may be easily missed, leading to inappropriate management of each cancer. We describe a patient found to have synchronous seminoma and Hodgkin Lymphoma and discuss the effects of the dual diagnoses on his evaluation and care. Case presentation: A 59 year old male with no significant medical history presented with progressive swelling and erythema of the right testis. Testicular cancer was suspected and he underwent a radical right inguinal orchiectomy. Pathology revealed a 5.7cm seminoma of the testis with lymphovascular invasion and without spermatic cord involvement (pT2) (Fig. 1). His tumor markers including AFP, LDH, and Beta-HCG were normal (S0). A CT scan of the chest, abdomen and pelvis followed by a PET/CT revealed enlarged, hypermetabolic mediastinal, hilar and periportal lymphadenopathy interpreted by the radiologist as concerning for metastatic disease. Given the atypical distribution for lymphadenopathy from testicular seminoma, an excisional biopsy of a left hilar node was performed and revealed Classical Hodgkin Lymphoma with IHC positive for CD15, CD30 and PAX-5 (Fig 2). He denied any B-symptoms and his bone marrow was uninvolved by lymphoma (stage IIIA). Adjuvant therapy for his germ cell tumor, otherwise an important consideration, was deferred and he began chemotherapy with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) for 6 cycles. Interim PET/CT after 2 cycles of ABVD showed a complete response. He has completed 6 cycles of ABVD and chose observation as opposed to single dose of adjuvant carboplatin for his seminoma and is currently under surveillance for both malignancies. Discussion: The unusual coexistence of Hodgkin Lymphoma and seminoma has rarely been documented in medical literature, with three other cases previously reported (2, 3). In each case a biopsy of lymphadenopathy, primarily outside the retroperitoneum, yielded a diagnosis of lymphoma. Both Hodgkin Lymphoma and germ cell tumors commonly involve lymph nodes and present in young men. Lymphadenopathy may understandably be assumed to represent metastatic disease in a young man with known testicular cancer. Clinical vigilance is necessary to question the nature of atypical sites of lymphadenopathy in such a patient, and to pursue the possibility of an alternate diagnosis with a lymph node biopsy. A missed diagnosis of lymphoma in such a patient would also mean harmful over-staging of the germ cell tumor. While these two cancers represent two of the most curable malignancies, their treatment is different and would be grossly wrong if each cancer is not correctly diagnosed and staged. Conclusion: Our report highlights the importance of clinical suspicion of a lymphoma in patients with another cancer and lymphadenopathy not typical of metastatic disease for that tumor type. In such situations a lymph node biopsy is crucial in order to proceed with the correct therapy of each malignancy. While the simultaneous presentation of Hodgkin Lymphoma and seminoma is rare, cases like ours highlight the importance of questioning metastatic disease when lymphoma seems to be a possibility. References 1. Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429-39 2. Dexeus FH, Kilbourn R, Chong C, et al: Association of germ cell tumors and Hodgkins disease. Urology 37:129-134, 1991 3. Gerl, A., Clemm, C., Salat, C., Mittermüller, J., Bomfleur, W. and Wilmanns, W. Testicular cancer and Hodgkin disease in the same patient. (1993) Cancer, 71: 2838-2840. Figure 1 Testicular mass- Seminoma Figure 1. Testicular mass- Seminoma Figure 2 Lymph node biopsy- Classic Hodgkin's lymphoma Figure 2. Lymph node biopsy- Classic Hodgkin's lymphoma Disclosures No relevant conflicts of interest to declare.


Blood ◽  
1993 ◽  
Vol 82 (8) ◽  
pp. 2510-2516 ◽  
Author(s):  
AC Lambrechts ◽  
PE Hupkes ◽  
LC Dorssers ◽  
MB van't Veer

Abstract Stage I and II follicular non-Hodgkin's lymphoma (NHL) is clinically defined as a localized disease. To study the possibility that this disease is in fact disseminated, we used the sensitive polymerase chain reaction (PCR) method using translocation (14;18) as marker. Samples from 21 patients who were clinically diagnosed with stage I or II follicular NHL were analyzed for the presence of t(14;18)-positive cells using PCR. We analyzed (1) the diagnostic lymph node biopsy and (2) the peripheral blood or bone marrow samples from these patients. Translocation (14;18) cells were detected in the diagnostic lymph node biopsies of 12 patients. In 9 of these patients, t(14;18)-positive cells were detected in peripheral blood and/or bone marrow samples at diagnosis and/or after therapy. Thus, in 75% of the follicular NHL patients carrying the t(14;18) as a marker for lymphoma cells, t(14;18)- positive cells were detected in peripheral blood and bone marrow at diagnosis and after therapy. Our results show that t(14;18)-positive cells can be detected in the circulation of patients with stage I and II follicular NHL, indicating that, although diagnosed as localized, the disease is disseminated.


2010 ◽  
Vol 3 ◽  
pp. CCRep.S5243 ◽  
Author(s):  
Baldeep Wirk

Introduction There is a reported association between sarcoidosis and malignancy. This is particularly true for lymphomas and is known as the sarcoidosis-lymphoma syndrome. Case report A 49 year old Caucasian female presented with mediastinal and axillary lymphadenopathy. An excisional axillary lymph node biopsy showed classical Hodgkin's lymphoma, nodular sclerosis subtype. She received six cycles of conventional chemotherapy achieving a complete remission with no evidence of any lymphadenopathy on restaging imaging. However, one month after completion of chemotherapy, she developed new onset of progressive mediastinal lymphadenopathy. A mediastinoscopy and biopsy was performed showing noncaseating granulomata and the patient was diagnosed with a sarcoid reaction. Conclusion Sarcoidosis and sarcoid reactions must be considered in the differential diagnosis when assessing patients with persistent or enlargening masses after chemotherapy treatment for Hodgkin's lymphoma, especially since this is associated with a better prognosis. A tissue biopsy is essential prior to starting chemotherapy for presumed relapsed malignancy or persistent disease so as to avoid inappropriate treatment.


2011 ◽  
Vol 48 (3) ◽  
pp. 345 ◽  
Author(s):  
R Maharaj ◽  
V Naraynsingh ◽  
S Hariharan ◽  
PJ Shukla ◽  
D Dan

2015 ◽  
Vol 21 (1) ◽  
pp. 3-6 ◽  
Author(s):  
Omgo E. Nieweg ◽  
Roger F. Uren ◽  
John F. Thompson

2017 ◽  
Vol 116 (8) ◽  
pp. 1185-1192 ◽  
Author(s):  
Alison B. Durham ◽  
Jennifer L. Schwartz ◽  
Lori Lowe ◽  
Lili Zhao ◽  
Andrew G. Johnson ◽  
...  

2017 ◽  
Vol 21 (2) ◽  
Author(s):  
Rachel Hubbard ◽  
Jalpa Kotecha ◽  
Thomas Nash ◽  
Yu Jin Lee ◽  
Nasir Khan ◽  
...  

Hodgkin’s lymphoma and disseminated Mycobacterium avium complex (MAC) infection share similar clinical features; both may affect human immunodeficiency virus (HIV)-positive individuals. We discuss a patient with poorly controlled HIV-infection presenting with chest sepsis, dyspnoea and weight loss. Whilst the initial working diagnosis was that of MAC infection, pathology results had not met diagnostic criteria. Lymph node biopsy instead revealed classical Hodgkin’s lymphoma. We discuss the role of radiological examination in cases of diagnostic uncertainty.


2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
John Patrick O’Neill ◽  
Fiona Quinn ◽  
Anita Dowling ◽  
Jan Walker ◽  
Triona Hayes ◽  
...  

A composite lymphoma is the rare simultaneous occurrence of two or more distinct lymphomas within a single tissue or organ. Herein, we describe a case of a 51-year-old man presenting with a history of lower limb rash, fatigue, and bulky abdominopelvic lymphadenopathy. An excisional left iliac lymph node biopsy was notable for the composite presence of two distinct lymphoid neoplasms, nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), and follicular lymphoma (FL). Multiplex PCR and FISH analyses failed to demonstrate a t(14;18)(q32;q21) translocation in either composite lymphoma component. A clonal light-chain kappa (V/JC intron-kde) gene rearrangement was detected in the FL component only.


PEDIATRICS ◽  
1986 ◽  
Vol 78 (3) ◽  
pp. 514-515
Author(s):  
SUSAN B. MALLORY ◽  
D. H. BERRY

Methotrexate is not an infrequently used drug in chemotherapy protocols. The following, however, is an uncommon side effect of this medication. CASE REPORT A 13-year-old white boy was diagnosed as having non-Hodgkin's lymphoma by lymph node biopsy 2 years prior to the onset of his dermatitis. While on a fishing trip in May 1984, a mild sunburn developed after 1½ hours in the sun. Two days later, his sunburn was barely noticeable. He underwent chemotherapy which included highdose intravenous methotrexate with leucovorin rescue, as well as intrathecal methotrexate, cytarabine, and hydrocortisone. Shortly after the injection of intravenous methotrexate, he noted tingling and burning at the sites of his resolving sunburn.


Sign in / Sign up

Export Citation Format

Share Document